JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 48 filers reported holding JANUX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,164,565 | -5.3% | 4,579,818 | +11.5% | 1.24% | -8.4% |
| Q2 2023 | $48,749,437 | +154.1% | 4,106,945 | +159.0% | 1.36% | +93.9% |
| Q1 2023 | $19,186,692 | -0.9% | 1,585,677 | +7.8% | 0.70% | -14.2% |
| Q4 2022 | $19,364,299 | -2.7% | 1,470,334 | 0.0% | 0.82% | -0.6% |
| Q3 2022 | $19,908,000 | +10.9% | 1,470,334 | 0.0% | 0.82% | -5.2% |
| Q2 2022 | $17,953,000 | +9.6% | 1,470,334 | +28.7% | 0.87% | +32.4% |
| Q1 2022 | $16,381,000 | -18.4% | 1,142,340 | +12.3% | 0.66% | -10.2% |
| Q4 2021 | $20,072,000 | -8.8% | 1,017,314 | 0.0% | 0.73% | -15.1% |
| Q3 2021 | $22,005,000 | -25.0% | 1,017,314 | -13.5% | 0.86% | -21.9% |
| Q2 2021 | $29,358,000 | – | 1,176,681 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |